Related Experiment Videos
2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients
The American Journal of Dermatopathology
|February 23, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Challenges to genetic testing for germline mutations associated with breast cancer among African Americans
Cancer treatment reviews·2024
Biopsied Cutaneous Adverse Effects of PD-1 and PD-L1 Checkpoint Inhibitors and Progression-free Survival: A Retrospective Case Series of 75 Patients.
The American Journal of dermatopathology·2026
WNT/β-Catenin-Activated Rosette-Forming Carcinoma With Sarcomatoid Differentiation.
The American Journal of dermatopathology·2026
Hidden Malignancy: Predominantly InSitu Porocarcinoma Arising in a Poroma.
The American Journal of dermatopathology·2026
Perineal Nodular Induration of the Cyclist: A Dermatopathologic Study of Eight Cases with Practical Diagnostic Clues.
The American Journal of dermatopathology·2026
Majocchi Granuloma-like Deep Follicular Granulomatous Eruption Secondary to Aspergillus niger in an Immunocompetent Male.
The American Journal of dermatopathology·2026
Granular Cell (Granular-type) Fibrous Papule of the Face: Case Report and Literature Review Emphasizing Morphologic and Immunohistochemical Pitfalls.
The American Journal of dermatopathology·2026
Broad-spectrum host-targeting antivirals for rhinovirus infections: mechanisms and future perspectives.
Frontiers in immunology·2026
Colchicine for cardiovascular secondary prevention: evidence from recent trials and meta-analyses.
Current opinion in cardiology·2026